Tesamorelin 10mg
Tesamorelin (TH9507) is a synthetic analog of human GHRH(1-44)-NH2 with a trans-3-hexenoyl moiety attached to the N-terminal Tyr1 residue. The cited preclinical study examined resistance to enzymatic deactivation, plasma degradation and GH/IGF-1 responses. This listing contains 10mg of lyophilized material. Supplied strictly for in-vitro research and laboratory use only. Not for human or animal use.
Strength
Select Option
2+ save 5% · 5+ save 10% · 10+ save 20%
- Free Priority shipping on US orders over $100
- Ships same day on orders before 2 PM MST
- Plain, secure packaging
- Reported measurements · lot TSM-20260828-01Bioviridian Inc. · COA8893: purity 99.74%; content 10.35 mg.
- Stock-solution arithmetic — Tesamorelin concentration calculator
Batch Tracking
Batch #
TSM-20260828-01
Tested
2026-09-08
Purity
99.74%
Method
RP-HPLC (214 nm)
Mechanism of Action
Ferdinandi et al. (2007) characterized TH9507, the modified GHRH analog tesamorelin. Its N-terminal trans-3-hexenoyl modification conferred resistance to DPP-IV deactivation and slowed peptide degradation in rat, dog and human plasma in vitro. GH and IGF-1 responses were also measured in preclinical animal studies; those findings do not establish preservation of physiological GH pulsatility.
Properties
CAS Number
218949-48-5
Molecular Formula
C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight
5135.86 Da
Half-Life
~21-45 min (dog plasma)
Storage
Store lyophilized at 2-8°C. Reconstituted at 2-8°C, use within 14 days.
Shipping & Delivery
- Same-day dispatch on orders placed before 2 PM MST (Arizona — no daylight saving).
- US shipping from $5. Free Priority on orders $100+ (before discounts).
- Plain, unmarked packaging — no branding or product names on the outside.
- Ships to all 50 states, DC, Puerto Rico & the U.S. Virgin Islands; tracking emailed on every order.
Quality & Testing
- Independently tested by Bioviridian Inc. — identity by LC-MS/MS, purity by RP-HPLC (214 nm).
- Reported measurements on lot TSM-20260828-01:Bioviridian Inc. · COA8893: purity 99.74%; content 10.35 mg.
- USA-based; dispatched from Phoenix, Arizona.
- Supplied strictly for in-vitro laboratory research — not for human use.
Research Applications
References & Citations
(1)Non-clinical pharmacology and safety evaluation of TH9507, a human growth hormone-releasing factor analogue
Ferdinandi ES, Brazeau P, High K, et al.
Other strengths
Research Use Only
This product is intended strictly for in-vitro research, educational, and laboratory use. Not for human consumption. The information provided is based on published research and does not constitute medical advice.